4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-19-000007
Chief Executive Officer gave up 34,139 shares (to pay taxes)
- Chief Executive Officer acquired 120,100 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kim Jong Joseph · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-05 | Exercise or conversion : show line 1 in the form | +120,100 | 2,428,594 | D | ||
| 2019-03-05 | Shares withheld for taxes : show line 2 in the form | −34,139 | $3.61 | $123,242 | 2,394,455 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2019-03-05 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −120,100 | 120,100 | 240,200 | D |
Loading xslF345X03/wf-form4_155199657903918.xml…